טוען...
The evolution of recombinant thrombolytics: Current status and future directions
Cardiovascular disorders are on the rise worldwide due to alcohol abuse, obesity, hypertension, raised blood lipids, diabetes and age-related risks. The use of classical antiplatelet and anticoagulant therapies combined with surgical intervention helped to clear blood clots during the inceptive year...
שמור ב:
| הוצא לאור ב: | Bioengineered |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Taylor & Francis
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5553328/ https://ncbi.nlm.nih.gov/pubmed/27696935 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21655979.2016.1229718 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|